We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$14.2B
AUM Growth
+$2.62B
Cap. Flow
+$1.85B
Cap. Flow %
13.06%
Top 10 Hldgs %
32.74%
Holding
1,046
New
405
Increased
233
Reduced
157
Closed
205

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$106M
2
TSLA icon
Tesla
TSLA
+$96.4M
3
CRWD icon
CrowdStrike
CRWD
+$90.7M
4
RGTI icon
Rigetti Computing
RGTI
+$89.2M
5
HUM icon
Humana
HUM
+$74.7M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Financials 8.06%
3 Healthcare 7.56%
4 Consumer Discretionary 5.89%
5 Communication Services 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTJ
826
Intelligent Group
INTJ
$4.84M
$16.7K ﹤0.01%
+1,670
New +$29.3K
FGL
827
Founder Group Ltd
FGL
$1.12M
$14.7K ﹤0.01%
+319
New +$34.6K
ORGN
828
DELISTED
Origin Materials
ORGN
$10.4K ﹤0.01%
667
-333
-33% -$6.18K
MHUA
829
DELISTED
Meihua International Medical Technologies
MHUA
$9.46K ﹤0.01%
252
+90
+56% +$3.68K
SPKLW
830
Spark I Acquisition Corp Warrant
SPKLW
$8.3M
$6.23K ﹤0.01%
10,000
-8,833
-47% -$2.6K
QNTM
831
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.2M
$3.38K ﹤0.01%
+13,436
New +$265K
GDEVW icon
832
GDEV Inc Warrant
GDEVW
$72.9K
$2.93K ﹤0.01%
+80,000
New +$1.48K
LGCL icon
833
Lucas GC Ltd
LGCL
$75.3M
$2.91K ﹤0.01%
+468
New +$11.1K
EMO.RT
834
DELISTED
ClearBridge Energy Midstream Opportunity Fund Rights expiring Oct 10 2025
EMO.RT
$2.18K ﹤0.01%
+114,501
New +$10.3K
ISRLW
835
DELISTED
Israel Acquisitions Corp Warrant
ISRLW
$1.75K ﹤0.01%
10,000
-18,333
-65% -$3.51K
MNYWW
836
MoneyHero Ltd Warrants
MNYWW
$1.19K ﹤0.01%
11,320
ORGNW
837
DELISTED
Origin Materials Inc Warrants
ORGNW
$438 ﹤0.01%
30,000
KTTAW icon
838
Pasithea Therapeutics Warrants
KTTAW
$26K
$423 ﹤0.01%
25,000
SQFTW icon
839
Presidio Property Trust Inc Series A Warrants
SQFTW
$221K
$374 ﹤0.01%
+10,000
New +$349
ARKOW
840
DELISTED
ARKO Corp Warrant
ARKOW
$372 ﹤0.01%
40,000
RIV.RT
841
DELISTED
RiverNorth Opportunities Fund Rights
RIV.RT
$122 ﹤0.01%
+15,071
New +$225
A icon
842
Agilent Technologies
A
$39.5B
-4,914
Closed -$580K
AAL icon
843
CALL
American Airlines Group
AAL
$8.97B
-200,000
Closed -$2.24M
AAOI icon
844
Applied Optoelectronics
AAOI
$8.99B
-55,255
Closed -$1.42M
ABCL icon
845
AbCellera Biologics
ABCL
$1.73B
-20,000
Closed -$68.6K
ABOS icon
846
Acumen Pharmaceuticals
ABOS
$157M
-33,300
Closed -$38.6K
ACRS icon
847
Aclaris Therapeutics
ACRS
$765M
-14,400
Closed -$20.4K
ADBE icon
848
PUT
Adobe
ADBE
$84.3B
-100,000
Closed -$38.7M
AI icon
849
C3.ai
AI
$1.27B
-10,170
Closed -$250K
AIP icon
850
Arteris
AIP
$1.54B
-41,500
Closed -$395K

Similar funds

Marex Group's Q3 2025 Portfolio in Review

As of Q3 2025, Marex Group held 1,046 positions worth $14.2B, up 23% from $11.5B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marex Group deployed $1.85B of net new capital in Q3 2025, opening 405 new positions and adding to 233 existing holdings. Its largest new stake was Coinshares Bitcoin ETF: 16,940,000 shares worth $548M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Intuit, an estimated $106M trimmed.

  • Marex Group's largest Q3 2025 buy was Coinshares Bitcoin ETF: 16,940,000 shares worth $548M.
  • Marex Group added most to iShares Bitcoin Trust in Q3 2025, an estimated $381M increase.
  • Marex Group's biggest Q3 2025 reduction was Intuit, cutting an estimated $106M.
  • Marex Group fully exited Humana in Q3 2025, selling an estimated $74.7M.
  • Marex Group's ten largest holdings make up 33% of its $14.2B portfolio in Q3 2025.
  • Marex Group opened 405 new positions and closed 205 in Q3 2025.
  • Marex Group's portfolio value rose 23% quarter-over-quarter to $14.2B.

Based on Marex Group's 13F filing for Q3 2025, filed 14 Nov 2025.